Methotrexate in Cardiac Sarcoidosis: Absence of Evidence Is Not Evidence of Absence

JACC Cardiovasc Imaging. 2024 Apr;17(4):465. doi: 10.1016/j.jcmg.2023.11.017.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunosuppressive Agents
  • Methotrexate / adverse effects
  • Myocarditis*
  • Predictive Value of Tests
  • Sarcoidosis* / diagnostic imaging
  • Sarcoidosis* / drug therapy

Substances

  • Methotrexate
  • Immunosuppressive Agents